FDA Recommends Pfizer’s Low-dose Vaccine for Kids 5 to 11

WASHINGTON (AP) U.S. health advisers have endorsed kid-size doses of Pfizer’s COVID-19 vaccine for younger children.

The vote Tuesday by the Food and Drug Administration panel moves the U.S. closer to vaccinating children ages 5 to 11.

The FDA isn’t bound by the panel’s recommendation and is expected to make its own decision within days.

If regulators agree, shots could begin as early as late next week. Young kids would get a third of the dose given to teens and adults.

A study found kid-size vaccinations are nearly 91% effective at preventing infections that cause symptoms.

Moderna also is studying its vaccine for young children.

Korie has worked in the broadcast industry for more than 20 years. She has a news producing background dating back to 1996, with positions at WCSH-6 in Portland, Maine, WMUR-TV in Manchester and the Executive Producer for NH1. She returns to Binnie Media as the News Director for News Talk Radio. Korie and Jack have similar backgrounds in the industry, and currently Co-Host Good Morning NH with Jack Heath. Korie lives in Salem and loves spending time at the beach, the gym, watching the NFL and dining out with family and friends.